Globus Medical Asset Resilience Ratio

Latest as of June 2026: 1.59%

Globus Medical asset resilience ratio. Globus Medical (GMED) has an Asset Resilience Ratio of 1.59% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Globus Medical defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$87.40 Million
Cash + Short-term Investments

Total Assets

$5.49 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Globus Medical (2012–2025)

Asset resilience ratio of Globus Medical from 2012 to 2025. This chart shows how Globus Medical's Asset Resilience Ratio has changed over time. Read GMED current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Globus Medical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Globus Medical (GMED) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $87.40 Million 1.59%
Total Liquid Assets $87.40 Million 1.59%

Asset Resilience Insights

  • Limited Liquidity: Globus Medical maintains only 1.59% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Globus Medical Industry Peers by Asset Resilience Ratio

Compare Globus Medical's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Applied BioCode
TW:6598
Medical Devices 9.75%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Radiant Innovation
TWO:3373
Medical Devices 0.82%
Impedimed Ltd
AU:IPD
Medical Devices 46.15%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%

Globus Medical Asset Resilience Ratio by Year (2012–2025)

Globus Medical asset resilience ratio by year from 2012 to 2025. The table below shows the annual Asset Resilience Ratio data for Globus Medical.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.59% $31.09 Million $5.30 Billion -1.42pp
2024-12-31 2.01% $105.62 Million $5.25 Billion +1.02pp
2023-12-31 0.99% $50.50 Million $5.09 Billion -13.24pp
2022-12-31 14.24% $295.59 Million $2.08 Billion +1.45pp
2021-12-31 12.79% $250.38 Million $1.96 Billion +1.64pp
2020-12-31 11.15% $187.34 Million $1.68 Billion +3.60pp
2019-12-31 7.56% $115.76 Million $1.53 Billion -7.82pp
2018-12-31 15.37% $199.94 Million $1.30 Billion -8.26pp
2017-12-31 23.63% $254.89 Million $1.08 Billion -0.44pp
2016-12-31 24.08% $223.36 Million $927.64 Million -2.40pp
2015-12-31 26.48% $220.88 Million $834.10 Million +5.67pp
2014-12-31 20.81% $146.44 Million $703.55 Million -5.49pp
2013-12-31 26.30% $148.96 Million $566.30 Million --
2012-12-31 0.00% $0.00 $447.13 Million --
pp = percentage points

About Globus Medical

NYSE:GMED USA Medical Devices
Market Cap
$9.87 Billion
Market Cap Rank
#2209 Global
#829 in USA
Share Price
$87.10
Change (1 day)
+9.45%
52-Week Range
$61.71 - $96.82
All Time High
$96.82
About

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more